The US Food and Drug Administration (FDA) on Thursday released its proposed commitment letter for the Prescription Drug User Fee Act (PDUFA VIII) program, outlining its performance goals and program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results